2023

1. Zhou F, Aroua N, Liu Y, Rohde C, Cheng J, Wirth AK, Fijalkowska D, Gollner S, Lotze M, Yun H, Yu X, Pabst C, Sauer T, Oellerich T, Serve H, Rollig C, Bornhauser M, Thiede C, Baldus C, Frye M, Raffel S, Krijgsveld J, Jeremias I, Beckmann R, Trumpp A, Muller-Tidow C. A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia. Cancer Discov. 2023;13(2):332-347.

2. Tober R, Schnetzke U, Fleischmann M, Yomade O, Schrenk K, Hammersen J, Glaser A, Thiede C, Hochhaus A, Scholl S. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia. J Cancer Res Clin Oncol. 2023;149(4):1569-1583.

3. Kayser S, Martinez-Cuadron D, Hanoun M, Stolzel F, Gil C, Reinhardt HC, Aguiar E, Schafer-Eckart K, Burgues JMB, Steffen B, Bernal T, Krause SW, Riaza R, Schliemann C, Cervera J, Kaufmann M, Torres-Minana L, Hanel M, Acuna-Cruz E, Jost E, Algarra JL, Crysandt M, Fransecky L, Cornago-Navascues J, Kraus S, Martinez-Lopez J, Einsele H, Niemann D, Neubauer A, Seggewiss-Bernhardt R, Scholl S, Klein SA, Schmid C, Schaich M, Schmidt-Hieber M, Zukunft S, Ho AD, Platzbecker U, Baldus CD, Muller-Tidow C, Thiede C, Bornhauser M, Serve H, Levis M, Montesinos P, Rollig C, Schlenk RF. Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4. Haematologica. 2023;108(1):34-41.

4. Eckardt JN, Stasik S, Rollig C, Sauer T, Scholl S, Hochhaus A, Crysandt M, Brummendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schafer-Eckart K, Schliemann C, Krause SW, Herbst R, Hanel M, Hanoun M, Kaiser U, Kaufmann M, Racil Z, Mayer J, Cerqueira T, Kroschinsky F, Berdel WE, Serve H, Muller-Tidow C, Platzbecker U, Baldus CD, Schetelig J, Siepmann T, Bornhauser M, Middeke JM, Thiede C. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome. Blood Cancer J. 2023;13(1):18.

5. Donato E, Correia N, Andresen C, Karpova D, Wurth R, Klein C, Sohn M, Przybylla A, Zeisberger P, Rothfelder K, Salih H, Bonig H, Stasik S, Rollig C, Dolnik A, Bullinger L, Buchholz F, Thiede C, Hubschmann D, Trumpp A. Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs. Blood Adv. 2023;7(6):1011-1018.